$AHR

American Healthcare REIT (AHR) raised its projected investment pipeline to $800 million from $650 million (May). In Q2, it completed $126.9 million of SHOP investments, taking yearly SHOP investments to $1.4 billion. Same-store SHOP NOI grew 20.5% y/y. AHR also reported a $197.5 million in-process development and expansion pipeline, with $72 million funded, and its stock rose 3.71% to $56.74.

American Healthcare REIT reported Q2 2026 GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, and NFFO attributable to controlling interest of $0.54 per diluted share. Same-store NOI rose 13.2% YoY. The company raised FY 2026 guidance, including NFFO per diluted share to $2.15-$2.19, and declared a $0.25 quarterly common dividend.

American Healthcare REIT (AHR) reported Q2 2026 earnings on Aug. 6. The company posted EPS of $0.54 versus an estimate of $0.17, and revenue of $670.96 million versus $669.80 million. The article also cites recent insider sales and institutional position changes, plus a median analyst price target of $57.

American Healthcare REIT (AHR) reported Q2 2026 net income of $30.6M and normalized FFO per share of $0.54. Same-Store NOI rose 13.2% year over year. The company raised full-year guidance for NFFO per share and Same-Store NOI growth, citing strong segment performance from SHOP and ISHC.

American Healthcare REIT, Inc. (AHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 ahr-ex99_2.htm EX-99.2 EX-99.2 Second Quarter 2026 Supplemental Talamore Senior Living Sun Prairie, WI Exhibit 99.2 Disclaimers Forward-Looking Statements Certain statements contained in this supplemental, filed in conjunction with the Second Quarter 2026 Earnings Press

Wall Street futures rose Tuesday after major U.S. indices fell Monday. The article lists analyst rating changes and price targets for stocks including Adobe (ADBE) downgraded to Underweight with a $240 target, Salesforce (CRM) cut to Equal Weight with a $185 target, and Microsoft (MSFT) assumed Overweight with a $600 target. It also cites moves for Datadog, Fortinet, Five Below, Gilead, and others.

American Healthcare REIT (NYSE: AHR) announced CEO and leadership changes. Danny Prosky will retire after taking medical leave. Chairman Jeff Hanson, who served as interim CEO since February, will become CEO, and COO Gabe Willhite will be promoted to president while keeping the COO role. Scott Estes was appointed lead independent director. AHR shares fell 1.23% to $56.38.

American Healthcare REIT Inc. (NYSE: AHR) appointed Jeff Hanson as CEO, after serving as interim CEO since February, when Danny Prosky took medical leave, according to the company. Prosky later decided to retire after a 35-year career, the firm said. Gabe Willhite was promoted to president, and Scott Estes was appointed to lead independent directors. AHR shares were about $56.79.

Analysts initiated coverage on several stocks. BMO Capital began coverage of Insmed (NASDAQ:INSM) with an Outperform rating and $192 target, and Axsome Therapeutics (NASDAQ:AXSM) with an Outperform rating and $310 target. Compass Point started American Healthcare REIT (NYSE:AHR) at Buy with $70 target. BMO initiated Trevi Therapeutics (NASDAQ:TRVI) at Outperform with $36 target, and Rodman & Renshaw started Eledon Pharmaceuticals (NASDAQ:ELDN) at Buy with $12 target.

American Healthcare REIT, Inc. (AHR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001632970 0001632970 2026-07-20 2026-07-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20,